EFX vs ZNTL · P/E 54, rev $3.35B vs $257.7M cap
Equifax Inc (EFX) versus Zentalis Pharmaceuticals Llc (ZNTL) — a side-by-side from cached financials, not a winner call.
Equifax Inc (EFX) is a consulting services company listed on US.
Zentalis Pharmaceuticals Llc (ZNTL) is a biotechnology company listed on NASDAQ.
Latest reported EFX revenue for 2026-06-30 was $3.35B. Net income was $355.4M. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
Latest reported ZNTL revenue for 2025-09-30 was $0. Net income was -$26.7M. ZNTL currently screens at market cap $257.7M.
EFX currently screens at market cap $33.00B and trailing P/E 54.0. ZNTL currently screens at market cap $257.7M.
Not investment advice. Open the EFX and ZNTL stock pages for the full models.
Not investment advice.